Search Within

Sergio Andres Giralt

Formats
  1. Meeting Abstract (632)
  2. Journal Article (373)
  3. Research Letter (18)
  4. Review (15)
  5. Guidelines (5)
  6. Editorial (4)
  7. Book Section (3)
  8. Correspondence (3)
Groups
  1. Bone Marrow Transplant (1053)
  2. Center for Hematologic Malignancies (1053)
  3. Department of Medicine (1053)
  4. Hematologic Malignancies, Division of (1053)
  5. Survivorship Research (687)
  6. CTCR Scholars (542)

More Groups

People
  1. Miguel-Angel Perales (423)
  2. Sean Devlin (373)
  3. Gunjan Shah (299)
  4. Michael Scordo (268)
  5. Heather Landau (253)
  6. Ann Jakubowski (240)

More People

Years
  1. 2025 (12)
  2. 2024 (55)
  3. 2023 (104)
  4. 2022 (77)
  5. 2021 (66)
  6. 2020 (91)

More Years

Publications
  1. Blood (304)
  2. Biology of Blood and Marrow Transplantation (275)
  3. Bone Marrow Transplantation (80)
  4. Clinical Lymphoma, Myeloma and Leukemia (60)
  5. Journal of Clinical Oncology (40)
  6. Transplantation and Cellular Therapy (36)

More Publications

Publishers
  1. Elsevier Inc. (384)
  2. American Society of Hematology (337)
  3. Nature Publishing Group (108)
  4. American Society of Clinical Oncology (42)
  5. Taylor & Francis Group (35)
  6. Ferrata Storti Foundation (13)

More Publishers

Results (1053)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Racial disparities in access to alternative donor allografts persist in the era of "Donors for all"
    Meeting Abstract

    Fingrut, W.; Politikos, I.; Davis, E.; Chinapen, S.; Naputo, K.; Cho, C.; Giralt, S. A.; Gyurkocza, B.; Jakubowski, A. A.; Papadopoulos, E. B.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Nutrition as a predictor of microbiome injury in allo-HCT
    Meeting Abstract

    Dai, A.; Adintori, P. A.; Docampo, M. D.; Brambilla, C. Z.; Buchan, M. L.; Gomes, A. L.; Burgos da Silva, M. D.; Markey, K. A.; Devlin, S. M.; Clurman, A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Rational targets in systemic AL amyloidosis
    Meeting Abstract

    Bal, S.; Dogan, A.; Hassoun, H.; Mailankody, S.; Giralt, S. A.; Landau, H. J.
    Blood (2021)

    Fulltext@MSK | Save
  • MAIT and Vδ2 unconventional T cells predict favorable outcome after allogeneic HCT and are supported by a diverse intestinal microbiome
    Meeting Abstract

    Andrlova, H.; Miltiadous, O.; Dai, A.; Gardner, R.; El Daker, S.; Slingerland, J. B.; Giardina, P. A.; Clurman, A.; Gomes, A. L. C.; Nguyen, C. L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Compositional flux within the intestinal microbiota and risk for bloodstream infection with gram-negative bacteria
    Journal Article

    Stoma, I.; Littmann, E. R.; Peled, J. U.; Giralt, S.; van den Brink, M. R. M.; Pamer, E. G.; Taur, Y.
    Clinical Infectious Diseases (2021)

    Fulltext@MSK | Save
  • Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
    Journal Article

    Bewersdorf, J. P.; Derkach, A.; Gowda, L.; Menghrajani, K.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Successful incorporation of electronic patient-reported outcomes using PROMIS-29 into standard of care for lymphoma patients receiving CD19-directed chimeric antigen receptor T (CAR T) cell therapy
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Sauter, C.; Batlevi, C.; Dahi, P. B.; Lin, R.; Palomba, M. L.; Perales, M. A.; Giralt, S. A.
    Quality of Life Research (2021)

    Fulltext@MSK | Save
  • Trajectories of symptom and quality-of-life (QOL) recovery after autologous stem cell transplantation (ASCT) in multiple myeloma (MM): Secondary analysis of BMT CTN 0702 trial
    Meeting Abstract

    D'Souza, A.; Brazauskas, R.; Stadtmauer, E.; Pasquini, M.; Hari, P.; Bashey, A.; Devine, S.; Efeberra, Y.; Ganguly, S.; Gasparetto, C.; more...
    Quality of Life Research (2021)

    Fulltext@MSK | Save
  • MASS-FIX versus standard methods to predict for PFS and OS among multiple myeloma patients participating on the STAMINA trial
    Meeting Abstract

    Dispenzieri, A.; Krishnan, A. Y.; Arendt, B.; Dasari, S.; Efebera, Y. A.; Geller, N.; Giralt, S.; Hahn, T.; Kohlhagen, M. C.; Landau, H. J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • The results of multicenter phase II, double-blind placebo-controlled trial of maintenance ixazomib after allogeneic hematopoietic cell transplantation (alloHCT) for high-risk multiple myeloma (MM) from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 1302)
    Meeting Abstract

    Nishihori, T.; Bashir, Q.; Pasquini, M. C.; Martens, M.; Wu, J.; Alsina, M.; Efebera, Y. A.; Gasparetto, C.; Geller, N.; Giralt, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save